Inverness Finds New Revenue Stream Following Pfizer Settlement
This article was originally published in The Gray Sheet
Executive Summary
Inverness Medical's pregnancy test patent litigation settlement with Pfizer may lead to future collaborations between the firms related to the contended technology
You may also be interested in...
Pfizer, Inverness Agree To Work Together On Digital e.p.t. Pregnancy Test
Pfizer soon will sell a digital version of its e.p.t. pregnancy test kit under an agreement with Inverness Medical Innovations allowing the drug firm to use patented technology from Inverness' Clearblue Easy Digital product
Pfizer, Inverness Agree To Work Together On Digital e.p.t. Pregnancy Test
Pfizer soon will sell a digital version of its e.p.t. pregnancy test kit under an agreement with Inverness Medical Innovations allowing the drug firm to use patented technology from Inverness' Clearblue Easy Digital product
Inverness Expands Diagnostics Focus To Cardiac R&D
Inverness Medical Innovations plans to initiate a cardiac diagnostics portfolio with a home-use prothrombin test launch at the end of 2004